I now have all the key textbook content needed. Let me compile the comprehensive viva-style answer.
Recurrent Proximal Weakness — Viva-Style Deep Dive
Q1. What are the major categories causing recurrent (episodic) proximal weakness?
VIVA FRAMEWORK — "CHAMP-MN"
| Category | Examples |
|---|
| Channelopathies | Hypo/HyperKPP, Paramyotonia, Andersen-Tawil |
| Hormonal/Metabolic | Thyrotoxic PP, hypothyroid myopathy, Cushing's |
| Autoimmune NMJ | Myasthenia Gravis, Lambert-Eaton |
| Metabolic Myopathies | Pompe, McArdle, carnitine deficiency |
| Periodic (secondary) | Renal tubular acidosis, GI losses (secondary HypoKPP) |
| Mitochondrial | MELAS, CPEO — episodic weakness |
| Neuromuscular inflammatory | Polymyositis (periodic flares) |
SECTION 1: CHANNELOPATHIES
Q2. Classify the skeletal muscle channelopathies
CHANNELOPATHIES
├── CALCIUM CHANNEL (CACNA1S)
│ └── Hypokalemic Periodic Paralysis Type 1 (HypoPP-1) — most common
├── SODIUM CHANNEL (SCN4A)
│ ├── Hyperkalemic Periodic Paralysis (HyperKPP)
│ ├── Hypokalemic Periodic Paralysis Type 2 (HypoPP-2)
│ ├── Paramyotonia Congenita (PMC)
│ └── Potassium-Aggravated Myotonia (PAM)
├── CHLORIDE CHANNEL (CLCN1)
│ ├── Myotonia Congenita — Thomsen (AD)
│ └── Myotonia Congenita — Becker (AR)
└── POTASSIUM CHANNEL (KCNJ2)
└── Andersen-Tawil Syndrome (ATS)
Q3. Differentiate HypoPP vs HyperKPP clinically
| Feature | HypoKPP | HyperKPP |
|---|
| Gene/channel | CACNA1S (Ca²⁺, type 1) / SCN4A (Na⁺, type 2) | SCN4A (Na⁺ channel) |
| Serum K⁺ during attack | < 3.0 mEq/L | > 5.5 mEq/L (or normal) |
| Attack duration | Hours to days (longer) | Minutes to hours (shorter) |
| Attack frequency | Less frequent | More frequent |
| Triggers | High carbohydrate meal, insulin, rest after exercise, stress, hypothermia | Rest after exercise, K⁺ ingestion, metabolic acidosis, hypothermia, fasting |
| Time of onset | Often on waking in morning | Often during day |
| Myotonia | Absent | Present (eyelids, tongue) |
| Bulbar/respiratory | Spared | Spared |
| Reflexes during attack | Reduced/absent | Reduced/absent |
| ECG | Flat T waves, U waves, prolonged QT | Peaked T waves, wide QRS |
| Inheritance | AD | AD |
| Acute Rx | Oral/IV KCl; avoid glucose | Glucose + insulin; inhaled salbutamol; avoid K⁺ |
| Prophylaxis | Acetazolamide, low Na⁺/carbohydrate diet | Acetazolamide, frequent small meals, high carbohydrate |
"In hypoPP, total body K⁺ is not depleted — it has shifted intracellularly; so K⁺ replacement must be cautious to avoid rebound hyperkalemia." — Rosen's Emergency Medicine
Q4. What is Paramyotonia Congenita (PMC) — how does it differ?
- Mutation: SCN4A (Na⁺ channel gain-of-function)
- Myotonia that WORSENS with activity and cold — opposite of warm-up phenomenon
- Episodic paralysis can follow prolonged cold exposure
- Key exam distinction: Myotonia congenita → warm-up ✅ | Paramyotonia → warm-up ❌ (worsens)
- Exercise test: Short exercise → no drop in CMAP amplitude; Long exercise + cold → CMAP drops
Q5. Andersen-Tawil Syndrome (ATS) — "TRIAD"?
Triad:
- Periodic paralysis (hypo, hyper or normokalemic)
- Cardiac arrhythmias — prolonged QT, U waves, bidirectional VT → sudden cardiac death
- Dysmorphic features — low-set ears, hypertelorism, micrognathia, short stature, clinodactyly
KCNJ2 mutation (Kir2.1 potassium channel). Many patients need ICD implantation.
SECTION 2: METABOLIC MYOPATHIES
Q6. How do metabolic myopathies present with recurrent proximal weakness?
Core concept: Defect in energy supply to muscle → failure under metabolic stress
| Disease | Defect | Trigger | Clinical Clue |
|---|
| McArdle (GSD V) | Myophosphorylase (PYGM) | Anaerobic exercise (short, intense) | "Second wind" phenomenon; myoglobinuria; ischemic forearm test → no lactate rise |
| Pompe (GSD II) | Acid maltase (α-glucosidase) | Any exertion; respiratory failure | Proximal + respiratory weakness; macroglossia in infants; elevated CK; acid maltase assay diagnostic |
| Carnitine deficiency | CPT-I/II or carnitine transport | Prolonged exercise, fasting | Episodic weakness + rhabdomyolysis; myoglobinuria; lipid vacuoles on biopsy |
| Mitochondrial myopathy | OXPHOS chain defects | Exercise, metabolic stress | Elevated lactate/pyruvate; ragged-red fibers (Gomori trichrome); ophthalmoplegia (CPEO) |
| Thyrotoxic PP | Na⁺/K⁺-ATPase overactivity | High carbohydrate, exercise | HypoKPP + tremor, tachycardia, sweating; ↑ T₃/T₄, ↓ TSH; common in Asian males |
"Second wind" in McArdle — Patient rests briefly when muscles tire (lactic block), then oxidative metabolism takes over → weakness resolves and exercise continues. This is pathognomonic.
Q7. Ischemic Forearm Exercise Test — what does it show?
| Result | Interpretation |
|---|
| Normal: ↑ lactate + ↑ ammonia | Normal glycogenolysis |
| No rise in lactate, normal ammonia rise | GSD (glycogen utilization defect) — McArdle |
| No rise in ammonia, normal lactate | Myoadenylate deaminase deficiency |
| Both fail to rise | Improper effort / inadequate ischemia (false positive) |
Note: Non-ischemic version (without BP cuff) now preferred to avoid rhabdomyolysis.
SECTION 3: NMJ DISORDERS
Q8. Differentiate Myasthenia Gravis vs Lambert-Eaton Myasthenic Syndrome (LEMS)
| Feature | Myasthenia Gravis (MG) | Lambert-Eaton (LEMS) |
|---|
| Pathophysiology | Autoantibodies against post-synaptic AChR (or MuSK) → ↓ ACh binding | Autoantibodies against pre-synaptic VGCC (P/Q-type) → ↓ ACh release |
| Site of defect | Post-synaptic | Pre-synaptic |
| Muscle distribution | Ocular + bulbar predominantly; limbs later | Proximal limbs (legs > arms); ocular/bulbar mild |
| Characteristic weakness pattern | Fatigable — worsens with sustained activity | Facilitation — brief improvement with repeated activity, then fatigues |
| Ptosis | Yes, fatigable; improves with ice test | Mild or absent |
| Diplopia | Common | Rare |
| Reflexes | Normal | Hyporeflexia → improves after brief exercise (post-tetanic potentiation) |
| Autonomic features | Absent | Present: dry mouth, constipation, erectile dysfunction, blurred vision |
| Associated malignancy | Thymoma (10–15%) | Small cell lung carcinoma (~50%) |
| Antibodies | AChR Ab (80–90%); MuSK Ab (5–10%); double-seroneg (5–10%) | VGCC Ab (>85%) |
| RNS (3 Hz) | Decremental response (>10–15% drop) | Decremental at low freq; Incremental >100% at high freq (50 Hz) or post-exercise |
| SFEMG | Increased jitter ± blocking (most sensitive test) | Increased jitter |
| Treatment | Pyridostigmine, steroids, azathioprine, thymectomy, plasma exchange, IVIG, eculizumab, efgartigimod | Treat underlying cancer; 3,4-DAP (amifampridine); IVIG, plasma exchange, immunosuppression |
Q9. Describe the RNS (Repetitive Nerve Stimulation) pattern
MG LEMS
Low Hz (3Hz): DECREMENTAL ↓↓↓↓↓ DECREMENTAL ↓↓↓↓↓
High Hz (50Hz): No increment INCREMENTAL ↑↑↑↑ (>100%)
Post-exercise: Repair of decrement Marked increment (facilitation)
(brief) then post-activation
exhaustion after 3-4 min
Mnemonic: "MG = Post-synaptic = Decremental; LEMS = Pre-synaptic = Facilitation"
SECTION 4: CLINICAL DIFFERENTIATION TABLE (MASTER)
| Feature | HypoPP | HyperKPP | MG | LEMS | Metabolic Myopathy |
|---|
| Age of onset | Teens | Teens | Any (peak 20s F, 60s M) | 50s-60s | Childhood/any |
| Pattern of weakness | Proximal limbs | Proximal ± tongue/eyelids | Ocular, bulbar, limbs | Proximal legs | Proximal limbs |
| Fluctuation | Episodic attacks | Episodic attacks | Diurnal (worse evening) | Progressive ± brief facilitation | Exercise-triggered episodes |
| Reflexes | Absent during attack | Absent during attack | Normal | Hyporeflexic (improve post-exercise) | Normal (usually) |
| Myotonia | Absent | Present | Absent | Absent | Absent |
| Autonomic features | Absent | Absent | Absent | Dry mouth, impotence | Absent |
| Serum K⁺ | Low | High | Normal | Normal | Normal |
| CK | Normal/mildly ↑ | Normal | Normal | Normal | ↑↑ (markedly) |
| Myoglobinuria | Absent | Absent | Absent | Absent | Present (McArdle, CPT II) |
| EMG | Normal (inter-ictal) | Myotonic discharges | Normal / ↑ jitter SFEMG | Facilitation on RNS | Normal / myopathic |
SECTION 5: INVESTIGATION ALGORITHM
Q10. How do you investigate recurrent proximal weakness?
Step 1 — DURING attack (timing is critical)
- Serum K⁺ (critical — determines channelopathy subtype)
- ECG (hypoK → U waves; hyperK → peaked T)
- Serum CK (markedly elevated → metabolic; mildly elevated → inflammatory/dystrophic)
- Urine for myoglobin (rhabdomyolysis → McArdle, CPT II)
- Thyroid function (TSH, T₃, T₄) — if first episode of HypoKPP
Step 2 — BETWEEN attacks (baseline)
| Test | Target |
|---|
| Serum CK | ↑ → myopathy; normal → channelopathy, NMJ |
| EMG + NCS | Myotonic discharges → channelopathy; decremental RNS → MG; incremental → LEMS |
| SFEMG | Most sensitive for NMJ disease |
| AChR antibodies | MG (80–90% sensitivity) |
| MuSK antibodies | Seronegative MG |
| VGCC antibodies | LEMS (>85%) |
| CT chest | Thymoma (MG); SCLC (LEMS) |
| Short/long exercise test (NCS) | Channelopathies — CMAP amplitude drop post-exercise |
| Ischemic forearm test | GSD (no lactate rise) |
| Lactate/pyruvate ratio | Mitochondrial (>20:1 at rest) |
| Acid maltase (GAA) assay | Pompe disease (DBS/leukocytes) |
| Carnitine levels | CPT deficiency |
| Genetic panel | CACNA1S, SCN4A, CLCN1, KCNJ2 for channelopathies |
| Muscle biopsy | Definitive for metabolic myopathies (enzyme histochemistry, EM) |
| Brain/spine MRI | Rule out CNS/cord cause of weakness |
SECTION 6: HIGH-YIELD VIVA QUICK-FIRES
Q: What is the "second wind" sign and its significance?
A: In McArdle disease (GSD-V), initial exercise causes myalgia/cramps due to blocked glycogenolysis. After brief rest, oxidative metabolism compensates and the patient can continue — pathognomonic of PYGM deficiency.
Q: Why does LEMS spare the eyes but MG primarily affects them?
A: Ocular muscles have high-frequency NMJ firing and are especially dependent on ACh quantum content — post-synaptic receptor loss (MG) affects them maximally. LEMS affects ACh release across all muscle beds more uniformly, proximal limbs being most symptomatic.
Q: Thyrotoxic periodic paralysis — who gets it and why?
A: Asian males predominantly. Excess thyroid hormone upregulates Na⁺/K⁺-ATPase activity → intracellular K⁺ shift → HypoKPP attacks. Treat: non-selective beta-blocker (propranolol) acutely + antithyroid therapy prevents recurrence.
Q: What is post-tetanic potentiation in LEMS?
A: Rapid repetitive stimulation causes accumulation of Ca²⁺ at the presynaptic terminal → transiently overcomes the VGCC block → paradoxical increase in ACh release and strength. Clinically: patient's reflexes and power briefly improve after exercise.
Q: Andersen-Tawil — why is it unique among channelopathies?
A: Only channelopathy with a cardiac + skeletal + dysmorphic triad. KCNJ2 mutation affects Kir2.1 channels expressed in both cardiac and skeletal muscle and in bone development. Risk of sudden cardiac death from bidirectional VT mandates cardiology follow-up ± ICD.
Q: Which anesthetic agents are dangerous in channelopathies?
A:
- Succinylcholine → triggers myotonia/myotonic crisis in all myotonias; prolonged muscle rigidity
- Volatile agents (halothane, isoflurane) → can trigger hyperKPP attacks (membrane depolarization)
- NMBDs: both depolarizing and non-depolarizing should be used cautiously in LEMS (profound sensitivity)
Sources: Rosen's Emergency Medicine; Bradley and Daroff's Neurology in Clinical Practice; Barash Clinical Anesthesia 9e; Morgan & Mikhail Clinical Anesthesiology 7e; Goldman-Cecil Medicine